Impact of prostate gland volume on cryoablation prostate-specific antigen outcomes

Urology

Volumn 77, Issue 4, 2011, Pages 994-998

  Levy, David A ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CRYOABLATION; GLEASON SCORE; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM FISTULA;

AGED; CRYOSURGERY; DISEASE PROGRESSION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN SIZE; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 79953846589     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.08.010     Document Type: Article

References (11)

1. Zacarrian SA, Stone D, Clater M. Cryobiology. 1970;7:27-39.
2. Baust JG, Gage AA, Clarke D, et al. Cryosurgery - a putative approach to molecular-based optimization. Cryobiology. 2004;48:190-204. (Pubitemid 38482134)
3. Levy DA, Pisters LL, Jones JS. Primary cryoablation Nadir PSA and biochemical failure. J Urol. 2009;182:931-937.
4. Levy DA, Li J, Jones JS. Impact of disease burden on cryoablation PSA outcomes. Urology. 2010;75:478-481.
5. Roach M III, Hanks G, Thames H Jr., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965-974.
6. Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180:1993-2004.
7. Levy DA, Pisters LL, Jones JS. Prognostic value of initial salvage cryoablation PSA BJU Int. 2010;106:986-990.
8. Levy DA, Li J, Jones JS. Disease Burden predicts for favorable post salvage cryoablation PSA. Urology. 2010;76:1157-1161.
9. Karakiewicz PI, Bhojani N, Capitanio U, et al. External validation of the updated Partin tables in a cohort of north American men. J Urol. 2008;180:898-902.
10. Bhojani N, Salomon L, Capitanio U, et al. External validation of the updated Partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys. 2009;73:347-352.
11. D'Amico AV, Moul J. Carroll PR, et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era. J Clin Oncol. 2003;21:2163-2172. (Pubitemid 46606365)